SEC Division of Corporation Finance no-action letter: Biomet, Inc.

The Staff of the Division of Corporation Finance concurs that the effectiveness of a post-effective amendment to a Market-Making Registration Statement on Form S-1 during the fiscal year ended May 31, 2015 does not preclude Biomet, Inc. and its 100% owned subsidiaries from filing a Form 15 to suspend their reporting obligations under Section 15(d) of the Securities Exchange Act of 1934. This relief allows the Registrants to suspend the duty to file Annual Reports on Form 10-K for the fiscal year ended May 31, 2015, provided they file the Form 15 on or prior to August 29, 2015. The Staff's agreement is based on the redemption of all outstanding Notes, the absence of record holders for the securities, and the Registrants' compliance with the requirements of Rule 12h-3(a) and (b).

SEC published 7 documents in the last 30 days — get each new one by email the day it lands.

Rule 12h-3 under the Securities Exchange Act of 1934
Section 15(d) of the Securities Exchange Act of 1934
July 24, 2015

Office of Chief Counsel

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re: Biomet, Inc.

File No. 333-194855

Ladies and Gentlemen:

We are writing on behalf of Biomet, Inc., an Indiana corporation (the “Company”), to request that a no-action letter be issued advising us that the staff of the Division of Corporation Finance

Read the rest free, and get an email when SEC publishes again

Email me when SEC publishes something newOne email per publication, same day. Sign in below to keep reading.

Lineage: In force

amendssupersedesissued underrefers toproposed or not in RegAlertarrows run from the older text to the one that changes it

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works